Q2 2024 · 13F-HR
CAXTON CORPholdings as filed
Filed 2024-08-14 · accession 0000919574-24-004535
$19.7M
Reported value
12
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $11.5M | 58.3% | 5,113,348 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $5.7M | 28.7% | 1,318,967 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $1.0M | 5.15% | 1,869 | Common | SOLE |
| 084670702 | BRK/B | BERKSHIRE HATHAWAY INC DEL | $417,070 | 2.11% | 1,025 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $286,331 | 1.45% | 17,851 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE INC | $219,059 | 1.11% | 30,383 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $183,760 | 0.93% | 13,900 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $172,359 | 0.87% | 22,981 | Common | SOLE |
| 608550208 | MTEMEUR | MOLECULAR TEMPLATES INC | $157,396 | 0.80% | 136,866 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $43,465 | 0.22% | 43,465 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $36,899 | 0.19% | 18,403 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $21,160 | 0.11% | 17,488 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.